Reymundo Lozano MD

PubMed

• The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity.
  Lindsay M Oberman, Elizabeth Berry-Kravis, Dejan B Budimirovic, Craig A Erickson, Randi J Hagerman
  Journal of Child and Adolescent Psychopharmacology. 2025-02-06
• 5 citations
  Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome.
  Walter E Kaufmann, Melissa Raspa, Carla M Bann, Julia M Gable, Holly K Harris
  Journal of Autism and Developmental Disorders. 2024-02-01
• Gait Abnormalities in Children with Phelan-McDermid Syndrome.
  Yitzchak Frank, Tess Levy, Reymundo Lozano, Kate Friedman, Slayton Underwood
  Journal of Child Neurology. 2023-12-01

Journal Articles

• New FOXP1 mutation causes autism and severe hypotonia  
  Lozano R, Lozano C, Deroziti P, Human Mutation, 1/20/2015
• Methadone use in a male with the fmr1 premutation and FXTAS  
  Muzar Z, Lozano R, Schneider A, Adams P., Faradz S, Tassone F, Hagerman R, AJMG, 1/10/2015
• A novel ZRS mutation leads to preaxial polydactyly type 2 in a heterozygous form and Werner Mesomelic syndrome in a homozygous form  
  VanderMeer J., Lozano R., Sun M., Xue Y., Wang Jabs E., Wilcox W., Ahituv N., Hum Mutat, 1/28/2014
• Modulation of the GABAergic pathway for the treatment of fragile X syndrome  
  Lozano R., Hare E., and Hagerman R, Neuropsychiatr Dis Treat, 1/16/2014
• Clinical and laboratorial comparison of two compound heterozygous daughters with premutation on the FMR1 gene  
  Basuta K., Lozano R, Tassone F., Schneider A., Hessl D, Hagerman R, Clin Genet, 1/8/2014
• Genomic Studies in Fragile X Premutation Carriers  
  Lozano R., Hagerman R. J., Duyzend M., Budimirovic D., Evan E. E., Tassone F, J Neurodev Disord, 1/1/2014
• CASE REPORT: Clinical Exome Sequencing Identifies de novo Mutations in the KMT2A (MLL) gene Possibly Causing Atypical Wiedemann- Steiner Syndrome in Two Unrelated Indi...  
  Strom S, Lozano R., Lee H., Dorani N., Mann J., O'Lague P., Deignan J., Vilain E., Nelson S., Grody W., Quintero-Rivera F, BMC Med Genet, 1/1/2014
• Association Between Macroorchidism and Intelligence in FMR1 Premutation Carriers  
  Lozano R., Summers S., Lozano C., Mu Y., Hessl D., Nguyen D., Tassone F., Hagerman R, BMC Medical Genetics, 1/1/2014
• Fragile x Spectrum Disorders  
  Lozano R, Alba C, Hagerman R, Intractable & Rare Diseases Research, 1/1/2014
• Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome  
  Muzar Z and Lozano R, Intractable & Rare Diseases Research, 1/1/2014
• Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders  
  Chechi T., Siyahian S, Thairu L, Hagerman R and Lozano R, Intractable & Rare Diseases Research, 1/1/2014
• Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases  
  Muzar Z, Adams P, Schneider A, Hagerman R and Lozano R, Intractable & Rare Diseases Research, 1/1/2014
• Parent-delivered touchscreen intervention for children with fragile X syndrome  
  Diez-Juan M, Schneider A, Phillips T and Lozano R, Tassone F, Solomon M, Hagerman R, Intractable & Rare Diseases Research, 1/1/2014
• Translational research guided by animal studies in Fragile X Disorders  
  Randi Hagerman, Reymundo Lozano*, Andrea Schneider, IRDR, 1/1/2014
• Association of B-defensin, 1 Single Nucleotide Polymorphisms with Atopic Dermatitis  
  Prado-Montes , Garcia M., Lozano R., Gallegos-Arreola M., Sandoval-Ramirez L., Rodriguez N, Figuera E, International Archives of Allergy and Immunology, 1/1/2007
• Targeted Treatments in Fragile X Syndrome  
  Hare E., Hagerman R., Lozano R, Expert Opinion on Orphan Drugs
• Join now to see all

Books/Book Chapters

• New Developments in Treatment for Neurodevelopmental Disorders 
  Chapter: Treatment of Fragile X syndrome and Fragile X- associated Disorders 
  Lozano R., Hare E. and Hagerman REditors: Robert L. Hendren, Randi and Hagerman.
• Health Care for people with Intellectual and Developmental Disabilities across the lifespan 
  Chapter: Fragile X syndrome 
  Hare E., Lozano R, Partington L and Hagerman REditors: Rubin and Crocker.Edition 3rd,
• Molecular and genetic Basis of Neurological and Psychiatric Disease 
  Chapter: Genetic Basis of Psychiatric Diseases 
  Lozano R. Hare E. and Hagerman REdition 5th,

Abstracts/Posters

• Macroorchidism in Premutation Carriers
  Lozano R, International National Foundation for Fragile X syndrome, 1/1/2014
• Gabaergic Treatments for children with FXS
  Lozano R, International National Foundation for Fragile X syndrome, 1/1/2014
• FMR1 Base Second Hit Model in Premutation Carriers
  Lozano R, American Society of Human Genetics, 1/1/2014
• Genomic studies in premutation carriers
  Lozano R, UC Davis, First Medical Genomics conference, 1/1/2014
• Health Disparities in Clinical Trials
  Lozano R, 2nd Meeting Health Disparities and Genomics, San Francisco, CA, 1/1/2013
• FMR1 Premutation in Addition to a Second Hit Leads to ASD
  Lozano R, 1st International Meeting of FMR1 premutation, Perugia, Italy, 1/1/2013
• Double Heterozygous of FMR1 premutation
  Lozano R, 1st International Meeting of FMR1 premutation, Perugia, Italy, 1/1/2013
• Refining the Critical Region of the 2p15p16- Microdeletion Síndrome and Autism
  Lozano R, 52nd Annual Short Course on Medical and Experimental-Mammalian Genetics, 1/1/2011
• A novel Point Mutacion in a Family with Preaxial Polydactyly
  Lozano R, Cedars Sinai, Annual Research Week, Los Angeles, CA, 1/1/2011
• Jarcho Levin Syndrome
  Lozano R, Pediatric American Society, 1/1/2009
• Multiple Exostoses: Case Presentation
  Lozano R, National Meeting of Human Genetics, San Luis Potosi, Mexico, 1/1/2004
• Factors of the cephalic insulin release
  Lozano R, XI National Research W eek, Guadalajara, Mexico, 1/1/2001
• Join now to see all

Lectures

• Outreach engagement “Colombia project of Hope” 
  1/24/2015
• Genetic Diagnosis and treatments for Autism 
  1/12/2015
• Gabaergic treatments for FXS 
  1/24/2014
• Genomic studies in Premutation Carriers 
  1/14/2014
• New Mexican Mutation Causes Triphalangeal Thumb and Werner syndrome 
  1/14/2014
• Colombia Project of Hope 
  Sacramento, CA - 1/10/2014
• FXS and identification of targeted treatments for trials in Autism 
  1/10/2014
• Lessons Learn from Clinical Trials for FXS 
  Cancun, Mexico - 1/6/2014
• Autism Diagnosis, Clinical Management and Medical Treatment 
  Sacramento, CA - 1/4/2014
• Clinical Trials for Fragile X Syndrome 
  Orlando, FL - 1/29/2013
• Clinical trials for neurodevelopmental disorders and Fragile X Syndrome 
  Sacramento, CA - 1/19/2013
• Health disparities in Autism 
  1/12/2013
• Genetic Causes of Autism 
  Bogota, Colombia - 1/12/2013
• Workshop: Down syndrome 
  Sacramento, CA - 1/12/2013
• Hot topics in Genetics. From Genes to Pharmaceutical Compounds 
  1/10/2013
• Targeted Treatments for Fragile X Syndrome 
  1/6/2013
• Lesson Learn for Targeted Treatments for Fragile X Syndrome 
  Barcelona, Spain - 1/2/2013
• Join now to see all

Other

• University Radio/ Fragile X syndrome and Autism 
  Lozano R, University of Guadalajara
  1/1/2015
• Clinical, genetic and psychological considerations of neurological disorders: focus on intellectual disability 
  Lozano R, PCHD19 Alliance and Ambry Genetics, Autism awareness month webinar
  1/8/2014
• Clinic work-flow in the clinics at the MIND institute 
  Lozano R, MIND Institute, UC Davis advertisement
  1/1/2014
• Welcome Video MIND Institute Autism Awareness Month 
  Lozano R, MIND Institute, UC Davis
  1/1/2014
• Autism: causes and treatments, Community awareness 
  Lozano R, Telemundo
  1/1/2014
• Autism Series, Discussion for Parents 
  Lozano R, Telemundo
  1/1/2014
• Fragile X and Autism 
  Lozano R, Radio interview/ 94.7 FM
  1/1/2014
• Autism Interview, Latino awareness month 
  Lozano R, Univision Local Chanel
  1/1/2013
• Causes and treatment of autism, Community awareness 
  Lozano R, Telemundo
  1/1/2013
• Race Impacts Subspecialty Care in Autism 
  Lozano R, Medpage/Embargo Interview
  1/1/2013
• Join now to see all